GB0918375D0 - Construct - Google Patents

Construct

Info

Publication number
GB0918375D0
GB0918375D0 GBGB0918375.7A GB0918375A GB0918375D0 GB 0918375 D0 GB0918375 D0 GB 0918375D0 GB 0918375 A GB0918375 A GB 0918375A GB 0918375 D0 GB0918375 D0 GB 0918375D0
Authority
GB
United Kingdom
Prior art keywords
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0918375.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pirbright Institute
Original Assignee
Pirbright Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pirbright Institute filed Critical Pirbright Institute
Priority to GBGB0918375.7A priority Critical patent/GB0918375D0/en
Publication of GB0918375D0 publication Critical patent/GB0918375D0/en
Priority to ES10777059.6T priority patent/ES2652443T3/es
Priority to PH1/2012/500662A priority patent/PH12012500662A1/en
Priority to KR1020127011421A priority patent/KR101818934B1/ko
Priority to IN3093DEN2012 priority patent/IN2012DN03093A/en
Priority to BR112012009475A priority patent/BR112012009475B1/pt
Priority to PCT/GB2010/001807 priority patent/WO2011048353A2/en
Priority to HUE10777059A priority patent/HUE035889T2/en
Priority to CN201080058064.7A priority patent/CN102834507B/zh
Priority to JP2012534759A priority patent/JP2013507948A/ja
Priority to EP10777059.6A priority patent/EP2491118B1/en
Priority to RU2012120700/10A priority patent/RU2565537C2/ru
Priority to AU2010309648A priority patent/AU2010309648A1/en
Priority to US13/502,014 priority patent/US9243230B2/en
Priority to ZA2012/02882A priority patent/ZA201202882B/en
Priority to CO12080730A priority patent/CO6551678A2/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0918375.7A 2009-10-20 2009-10-20 Construct Ceased GB0918375D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB0918375.7A GB0918375D0 (en) 2009-10-20 2009-10-20 Construct
US13/502,014 US9243230B2 (en) 2009-10-20 2010-09-24 Construct for producing empty virus capsids
PCT/GB2010/001807 WO2011048353A2 (en) 2009-10-20 2010-09-24 Construct
CN201080058064.7A CN102834507B (zh) 2009-10-20 2010-09-24 用于生成空小rna病毒壳体的构建体
KR1020127011421A KR101818934B1 (ko) 2009-10-20 2010-09-24 엠티 피코르나 바이러스 캡시드의 생성을 위한 컨스트럭트
IN3093DEN2012 IN2012DN03093A (enExample) 2009-10-20 2010-09-24
BR112012009475A BR112012009475B1 (pt) 2009-10-20 2010-09-24 constructo
ES10777059.6T ES2652443T3 (es) 2009-10-20 2010-09-24 Construcción para la producción de cápsides vacías de picornavirus
HUE10777059A HUE035889T2 (en) 2009-10-20 2010-09-24 Construct for production of empty picornaviral capsids
PH1/2012/500662A PH12012500662A1 (en) 2009-10-20 2010-09-24 Construct for production of empty picornaviral capsids
JP2012534759A JP2013507948A (ja) 2009-10-20 2010-09-24 空のピコルナウイルスキャプシドを生成するための構築物
EP10777059.6A EP2491118B1 (en) 2009-10-20 2010-09-24 Construct for production of empty picornaviral capsids
RU2012120700/10A RU2565537C2 (ru) 2009-10-20 2010-09-24 Конструкция
AU2010309648A AU2010309648A1 (en) 2009-10-20 2010-09-24 Construct for production of empty picornaviral capsids
ZA2012/02882A ZA201202882B (en) 2009-10-20 2012-04-19 Construct for production of empty picornaviral capsids
CO12080730A CO6551678A2 (es) 2009-10-20 2012-05-16 Contructo para la producción de capsides picornavirales vacias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0918375.7A GB0918375D0 (en) 2009-10-20 2009-10-20 Construct

Publications (1)

Publication Number Publication Date
GB0918375D0 true GB0918375D0 (en) 2009-12-02

Family

ID=41462637

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0918375.7A Ceased GB0918375D0 (en) 2009-10-20 2009-10-20 Construct

Country Status (16)

Country Link
US (1) US9243230B2 (enExample)
EP (1) EP2491118B1 (enExample)
JP (1) JP2013507948A (enExample)
KR (1) KR101818934B1 (enExample)
CN (1) CN102834507B (enExample)
AU (1) AU2010309648A1 (enExample)
BR (1) BR112012009475B1 (enExample)
CO (1) CO6551678A2 (enExample)
ES (1) ES2652443T3 (enExample)
GB (1) GB0918375D0 (enExample)
HU (1) HUE035889T2 (enExample)
IN (1) IN2012DN03093A (enExample)
PH (1) PH12012500662A1 (enExample)
RU (1) RU2565537C2 (enExample)
WO (1) WO2011048353A2 (enExample)
ZA (1) ZA201202882B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111183D0 (en) 2011-06-30 2011-08-17 Animal Health Inst Peptide
MY172501A (en) 2011-11-03 2019-11-27 Sentinext Therapeutics Sdn Bhd Vaccines directed against human enteroviruses
SG10201810400TA (en) 2012-09-05 2018-12-28 Medicago Inc Picornavirus-like particle production in plants
CN105209067A (zh) 2013-03-26 2015-12-30 皮尔布赖特研究所 稳定的fmdv衣壳
US10004796B2 (en) * 2014-04-29 2018-06-26 National Health Research Institutes Adenoviral vector-based vaccine against enterovirus infection
CA2987159A1 (en) * 2015-06-15 2016-12-22 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine
US9975926B2 (en) 2015-12-08 2018-05-22 The United States of America, as Represented by the Secretary of Homeland Security Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles
US10385319B2 (en) * 2016-09-08 2019-08-20 The Governement of the United States of America, as represented by the Secretary of Homeland Security Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof
US10435695B2 (en) 2016-09-08 2019-10-08 The Government of the United States of America, as represented by the Secretary of Homeland Security Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences
US10308927B2 (en) * 2017-01-17 2019-06-04 The United States of America, as Represented by the Secretary of Homeland Security Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease
WO2019092027A1 (en) * 2017-11-09 2019-05-16 Boehringer Ingelheim Vetmedica Gmbh Sapelovirus immunogenic compositions and uses thereof
GB201812474D0 (en) 2018-07-31 2018-09-12 Autolus Ltd Nucleic acid construct
WO2020067027A1 (ja) * 2018-09-28 2020-04-02 一般財団法人阪大微生物病研究会 Ｖｌｐ発現ｃｈｏ細胞株の構築
US20230399363A1 (en) 2020-10-22 2023-12-14 Intervet Inc. Baculovirus expression vector
MX2023004542A (es) 2020-10-22 2023-05-08 Intervet Int Bv Vector de expresion de baculovirus.
WO2023021167A1 (en) 2021-08-20 2023-02-23 Intervet International B.V. Method of producing a foot and mouth disease virus virus-like particle
WO2023021168A1 (en) 2021-08-20 2023-02-23 Intervet International B.V. Method of producing a foot and mouth disease virus virus-like particle
US20240358816A1 (en) 2021-08-20 2024-10-31 Intervet Inc. Fmdv virus-like particle with stabilizing mutation
US20240374706A1 (en) 2021-08-20 2024-11-14 The Pirbright Institute Fmdv virus-like particle with double stabilizing mutation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712899C1 (de) 1997-03-27 1998-12-10 Christian Dr Probst Verfahren zur Herstellung nichtinfektiöser rekombinanter Picornavirus-Partikel
RU2143921C1 (ru) 1999-04-21 2000-01-10 Всероссийский научно-исследовательский институт защиты животных Вакцина против ящура типа а и способ ее изготовления
FR2810888B1 (fr) 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
EP1632247A1 (en) 2004-09-03 2006-03-08 Consejo Superior De Investigaciones Cientificas Nucleic acid sequences encoding FMDV proteins capable of associating into a virus-like particle
NZ542111A (en) 2005-08-30 2008-04-30 Otago Innovation Ltd Novel assay

Also Published As

Publication number Publication date
US20120258133A1 (en) 2012-10-11
RU2565537C2 (ru) 2015-10-20
ZA201202882B (en) 2013-06-26
BR112012009475A2 (pt) 2015-09-15
WO2011048353A3 (en) 2011-09-29
EP2491118A2 (en) 2012-08-29
BR112012009475B1 (pt) 2020-06-09
CO6551678A2 (es) 2012-10-31
RU2012120700A (ru) 2013-12-10
CN102834507B (zh) 2016-09-07
IN2012DN03093A (enExample) 2015-09-18
AU2010309648A1 (en) 2012-05-03
US9243230B2 (en) 2016-01-26
CN102834507A (zh) 2012-12-19
EP2491118B1 (en) 2017-11-08
KR20120069756A (ko) 2012-06-28
ES2652443T3 (es) 2018-02-02
JP2013507948A (ja) 2013-03-07
HUE035889T2 (en) 2018-05-28
KR101818934B1 (ko) 2018-01-17
PH12012500662A1 (en) 2012-10-22
WO2011048353A2 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
DK2442650T4 (en) Sublingualt apomorfin
EP2462514A4 (en) GREEN BOOKS
GB0918375D0 (en) Construct
EP2515891A4 (en) 3-keto-N-propargyl-1-aminoindan
EP2519921A4 (en) CALL TRACING
DK2464943T3 (en) Systemintegration
GB0900568D0 (en) Poymerisation
GB0900319D0 (en) Hydrocharger
EP2510125A4 (en) HYPER PRIMER
AU4240P (en) Tuckerbox xTriticosecale
AU4925P (en) Bonscawi Scaevola aemula
AU4924P (en) Bonscablue Scaevola aemula
EG26256A (en) Oxygen hookah
GB0900950D0 (en) Hangermate
GB0900367D0 (en) Shelta
GB0901386D0 (en) VacuRag
GB0901350D0 (en) Rec-cp
GB0901302D0 (en) Side-spin
GB0901193D0 (en) Birdcatcher2
GB0901192D0 (en) Seaid
GB0901126D0 (en) Eco-frame
GB0900953D0 (en) Leggettes
GB0901586D0 (en) Stormfighter

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)